标题
Statins and PCSK9 inhibitors: What is their role in coronavirus disease 2019?
作者
关键词
Coronavirus, Infection, PCSK9 inhibitors, SARS-CoV-2, Sepsis, Statin
出版物
MEDICAL HYPOTHESES
Volume 146, Issue -, Pages 110452
出版商
Elsevier BV
发表日期
2020-12-09
DOI
10.1016/j.mehy.2020.110452
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China
- (2020) Dawei Wang et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- (2020) Peng Zhou et al. NATURE
- Clinical Characteristics of Coronavirus Disease 2019 in China
- (2020) Wei-jie Guan et al. NEW ENGLAND JOURNAL OF MEDICINE
- COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options
- (2020) Tomasz J Guzik et al. CARDIOVASCULAR RESEARCH
- The Effect of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition on the Risk of Venous Thromboembolism
- (2020) Nicholas A. Marston et al. CIRCULATION
- Anti-inflammatory Action of Statins in Cardiovascular Disease: the Role of Inflammasome and Toll-Like Receptor Pathways
- (2020) Khadijeh Koushki et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- Deleterious effects of viral pneumonia on cardiovascular system
- (2020) Jiahao Duan et al. EUROPEAN HEART JOURNAL
- The liaison between respiratory failure and high blood pressure: evidence from COVID-19 patients
- (2020) Marco Vicenzi et al. EUROPEAN RESPIRATORY JOURNAL
- Familial hypercholesterolaemia and COVID‐19: triggering of increased sustained cardiovascular risk
- (2020) Alpo Vuorio et al. JOURNAL OF INTERNAL MEDICINE
- COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up
- (2020) Behnood Bikdeli et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Acute kidney injury in patients hospitalized with COVID-19
- (2020) Jamie S. Hirsch et al. KIDNEY INTERNATIONAL
- Use of renin–angiotensin–aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study
- (2020) Francisco J de Abajo et al. LANCET
- Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
- (2020) Yeming Wang et al. LANCET
- COVID-19: consider cytokine storm syndromes and immunosuppression
- (2020) Puja Mehta et al. LANCET
- Remdesivir for the Treatment of Covid-19 — Preliminary Report
- (2020) John H. Beigel et al. NEW ENGLAND JOURNAL OF MEDICINE
- ST-Segment Elevation in Patients with Covid-19 — A Case Series
- (2020) Sripal Bangalore et al. NEW ENGLAND JOURNAL OF MEDICINE
- Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19
- (2020) Muthiah Vaduganathan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical Characteristics of Covid-19 in New York City
- (2020) Parag Goyal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19
- (2020) Yan Zhang et al. NEW ENGLAND JOURNAL OF MEDICINE
- Potential Effects of Coronaviruses on the Cardiovascular System
- (2020) Mohammad Madjid et al. JAMA Cardiology
- Meta-analysis of Effectiveness of Statins in Patients with Severe COVID-19
- (2020) Chia Siang Kow et al. AMERICAN JOURNAL OF CARDIOLOGY
- COVID‐19—Associated dyslipidemia: Implications for mechanism of impaired resolution and novel therapeutic approaches
- (2020) Alexander V. Sorokin et al. FASEB JOURNAL
- Retraction: Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19. N Engl J Med. DOI: 10.1056/NEJMoa2007621.
- (2020) Mandeep R. Mehra et al. NEW ENGLAND JOURNAL OF MEDICINE
- Brief recommendations on the management of adult patients with familial hypercholesterolemia during the COVID-19 pandemic
- (2020) Maciej Banach et al. PHARMACOLOGICAL RESEARCH
- Evolocumab, a PCSK9‐Monoclonal Antibody, Rapidly Reverses Coronary Artery Endothelial Dysfunction in People Living With HIV and People With Dyslipidemia
- (2020) Thorsten M. Leucker et al. Journal of the American Heart Association
- Association of Cardiac Infection With SARS-CoV-2 in Confirmed COVID-19 Autopsy Cases
- (2020) Diana Lindner et al. JAMA Cardiology
- Endothelial dysfunction in COVID-19: Current findings and therapeutic implications
- (2020) Matthias P. Nägele et al. ATHEROSCLEROSIS
- PCSK9 loss-of-function variants and risk of infection and sepsis in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) cohort
- (2019) Kellie A. Mitchell et al. PLoS One
- PCSK9 in HIV infection: New opportunity or red herring?
- (2019) Massimiliano Ruscica et al. ATHEROSCLEROSIS
- Cholesterol membrane content has a ubiquitous evolutionary function in immune cell activation
- (2019) Fabrizia Bonacina et al. CURRENT OPINION IN LIPIDOLOGY
- Immune modulatory effects of statins
- (2018) Robert Zeiser IMMUNOLOGY
- PCSK9 as a Positive Modulator of Platelet Activation
- (2018) Marina Camera et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Statins Suppress Ebola Virus Infectivity by Interfering with Glycoprotein Processing
- (2018) Punya Shrivastava-Ranjan et al. mBio
- Cholesterol is important for the entry process of porcine deltacoronavirus
- (2018) Ji Hyun Jeon et al. ARCHIVES OF VIROLOGY
- Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial
- (2018) Carolyn S Calfee et al. Lancet Respiratory Medicine
- Hydroxymethylglutaryl-CoA reductase inhibitors (statins) for the treatment of sepsis in adults – A systematic review and meta-analysis
- (2018) B. Pertzov et al. CLINICAL MICROBIOLOGY AND INFECTION
- Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
- (2018) Gregory G. Schwartz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lipid testing in infectious diseases: possible role in diagnosis and prognosis
- (2017) Sebastian Filippas-Ntekouan et al. INFECTION
- Effects of PCSK9 Inhibitors on Other than Low-Density Lipoprotein Cholesterol Lipid Variables
- (2017) Theodosios D. Filippatos et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
- Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
- (2017) Marc S. Sabatine et al. NEW ENGLAND JOURNAL OF MEDICINE
- PCSK9 knock-out mice are protected from neointimal formation in response to perivascular carotid collar placement
- (2016) Nicola Ferri et al. ATHEROSCLEROSIS
- Biology of proprotein convertase subtilisin kexin 9: beyond low-density lipoprotein cholesterol lowering
- (2016) Giuseppe Danilo Norata et al. CARDIOVASCULAR RESEARCH
- PCSK9 inhibitors in sepsis: a new potential indication?
- (2016) Amir Abbas Momtazi et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Increased Plasma PCSK9 Levels Are Associated with Reduced Endotoxin Clearance and the Development of Acute Organ Failures during Sepsis
- (2016) John H. Boyd et al. Journal of Innate Immunity
- HIV and Hepatitis C–Coinfected Patients Have Lower Low‐Density Lipoprotein Cholesterol Despite Higher Proprotein Convertase Subtilisin Kexin 9 (PCSK9): An Apparent “PCSK9–Lipid Paradox”
- (2016) Payal Kohli et al. Journal of the American Heart Association
- Alirocumab, a Therapeutic Human Antibody to PCSK9, Does Not Affect CD81 Levels or Hepatitis C Virus Entry and Replication into Hepatocytes
- (2016) Aarti Ramanathan et al. PLoS One
- Tissue specific up regulation of ACE2 in rabbit model of atherosclerosis by atorvastatin: Role of epigenetic histone modifications
- (2015) Kulbhushan Tikoo et al. BIOCHEMICAL PHARMACOLOGY
- Toll-Like Receptor 3 Signaling via TRIF Contributes to a Protective Innate Immune Response to Severe Acute Respiratory Syndrome Coronavirus Infection
- (2015) Allison L. Totura et al. mBio
- Atorvastatin attenuates myocardial remodeling induced by chronic intermittent hypoxia in rats: Partly involvement of TLR-4/MYD88 pathway
- (2014) Xiao Yuan et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- A Practical Treatment for Patients With Ebola Virus Disease
- (2014) D. S. Fedson JOURNAL OF INFECTIOUS DISEASES
- PCSK9 is a critical regulator of the innate immune response and septic shock outcome
- (2014) K. R. Walley et al. Science Translational Medicine
- Statins as Regulators of Redox State in the Vascular Endothelium: Beyond Lipid Lowering
- (2013) Marios Margaritis et al. ANTIOXIDANTS & REDOX SIGNALING
- Treating influenza with statins and other immunomodulatory agents
- (2013) David S. Fedson ANTIVIRAL RESEARCH
- The safety of therapeutic monoclonal antibodies: Implications for cardiovascular disease and targeting the PCSK9 pathway
- (2013) A.L. Catapano et al. ATHEROSCLEROSIS
- Effect of Statin Therapy on Mortality in Patients With Ventilator-Associated Pneumonia
- (2013) Laurent Papazian JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Hepatitis C Virus Stimulates Low-Density Lipoprotein Receptor Expression To Facilitate Viral Propagation
- (2013) G. H. Syed et al. JOURNAL OF VIROLOGY
- Inhibition of NF- B-Mediated Inflammation in Severe Acute Respiratory Syndrome Coronavirus-Infected Mice Increases Survival
- (2013) M. L. DeDiego et al. JOURNAL OF VIROLOGY
- The effect of rosuvastatin on incident pneumonia: results from the JUPITER trial
- (2012) V. Novack et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Efficacy, safety, and tolerability of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 as monotherapy in patients with hypercholesterolaemia (MENDEL): a randomised, double-blind, placebo-controlled, phase 2 study
- (2012) Michael J Koren et al. LANCET
- Efficacy, safety, and tolerability of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 in combination with a statin in patients with hypercholesterolaemia (LAPLACE-TIMI 57): a randomised, placebo-controlled, dose-ranging, phase 2 study
- (2012) Robert P Giugliano et al. LANCET
- Understanding the potential role of statins in pneumonia and sepsis*
- (2011) Sachin Yende et al. CRITICAL CARE MEDICINE
- Association Between Use of Statins and Mortality Among Patients Hospitalized With Laboratory-Confirmed Influenza Virus Infections: A Multistate Study
- (2011) M. L. Vandermeer et al. JOURNAL OF INFECTIOUS DISEASES
- Pre-Admission Statin Use and In-Hospital Severity of 2009 Pandemic Influenza A(H1N1) Disease
- (2011) Stephen J. Brett et al. PLoS One
- Statin Adverse Effects
- (2009) Beatrice A Golomb et al. American Journal of Cardiovascular Drugs
- PCSK9 impedes hepatitis C virus infectionin vitroand modulates liver CD81 expression
- (2009) Patrick Labonté et al. HEPATOLOGY
- A Randomized Trial of Rosuvastatin in the Prevention of Venous Thromboembolism
- (2009) Robert J. Glynn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Statins and cardioprotection — More than just lipid lowering?
- (2009) Andrew Ludman et al. PHARMACOLOGY & THERAPEUTICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More